Athanasia Dasargyri

Company: CDR-Life

Job title: Preclinical Pharmacology Expert

Seminars:

Strategies for Clinical Dose Selection of CDR404: A MAGE-A4/HLA-A2 Antibody-Based T-Cell Engager 4:00 pm

• Using Quantitative Systems Pharmacology (QSP) modeling for dose escalation and FIH study design for CDR404 • We discuss the key preclinical pharmacological data used for generation of a QSP model for CDR404 • Forward-looking perspectives and next generation antibody-based TCEs targeting peptide-HLA on cancer cellsRead more

day: Day 2